Coloplast AS 

$5.84
316
+$0.08+1.39% Friday 20:00

統計

當日最高
5.91
當日最低
5.75
52週高點
10.03
52週低點
5.65
成交量
72,106
平均成交量
604,266
市值
1.21B
本益比
41.07
股息殖利率
6.13%
股息
0.36

即將到來

股息

6.13%股息殖利率
Jun 26
$0.08
Dec 25
$0.28
May 25
$0.08
Dec 24
$0.24
May 24
$0.07
10年成長
6.14%
5年成長
3.99%
3年成長
5.62%
1年成長
1.01%

財報

18Aug預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
0.61
0.74
0.86
0.99
預期EPS
0.9458128218
實際EPS
不適用

財務

13.01%利潤率
有盈利
2020
2021
2022
2023
2024
2025
8.56B營收
1.11B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 CLPBY 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Its extensive reach spans Denmark, the United States, the United Kingdom, France, and numerous other international regions. The company's activities are organized into three primary segments: Chronic Care, Interventional Urology, and Wound & Skin Care. Within Chronic Care, Coloplast provides advanced ostomy solutions, including the SenSura Mio, recognized for its adaptable fit and discretion, alongside other SenSura offerings and Brava brand accessories. This segment also delivers continence care products such as Conveen Active urine bags, SpeediCath catheters for diverse users, and the Peristeen transanal irrigation system. The Wound & Skin Care division features innovative dressings like the conforming Biatain Silicone and the hydrocolloid Comfeel. Additionally, it offers a broad spectrum of skin care items, encompassing bathing and cleansing products, moisturizers, skin protectants, antifungal treatments, hand cleansers, odor control solutions, and the specialized InterDry system for managing skin folds. Finally, the Interventional Urology segment is dedicated to crafting and commercializing surgical devices that address a range of urological and gynecological conditions, such as urinary stone disease, benign prostatic hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence.
Show more...
執行長
Mr. Anders Lonning-Skovgaard
員工
16741
國家
丹麥
ISIN
US19624Y2000

上市

0 Comments

分享你的想法

FAQ

Coloplast AS 今天的股價是多少?
CLPBY 目前價格為 $5.84 USD,過去 24 小時上漲了 +1.39%。在圖表上更密切關注 Coloplast AS 股價表現。
Coloplast AS 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Coloplast AS 的股票以代號 CLPBY 進行交易。
Coloplast AS 的股價在上漲嗎?
CLPBY 股票較上週上漲 +1.57%,本月下跌 -6.56%,過去一年 Coloplast AS 下跌 -37.87%。
Coloplast AS 的市值是多少?
今天 Coloplast AS 的市值為 1.21B
Coloplast AS 下一次財報日期是什麼時候?
Coloplast AS 將於 August 18, 2026 公布下一次財報。
Coloplast AS 上一季度的財報如何?
CLPBY 上一季度的財報為每股 0.95 USD,預估為 0.91 USD,帶來 +4.29% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Coloplast AS 去年的營收是多少?
Coloplast AS 去年的營收為 8.56BUSD。
Coloplast AS 去年的淨利是多少?
CLPBY 去年的淨收益為 1.11BUSD。
Coloplast AS 會發放股息嗎?
是的,CLPBY 的股息每 半年一次 發放一次。每股最新股息為 0.08 USD。截至今日,股息殖利率(FWD)% 為 6.13%。
Coloplast AS 有多少名員工?
截至 June 28, 2026,公司共有 16,741 名員工。
Coloplast AS 位於哪個產業?
Coloplast AS從事於Health & Wellness產業。
Coloplast AS 何時完成拆股?
Coloplast AS 上次拆股發生於 December 16, 2004,比例為 2:1。
Coloplast AS 的總部在哪裡?
Coloplast AS 的總部位於 丹麥 的 Humlebæk。